As expected, the treatment of colon cancer cells by LPS induced inflammatory response resulting in the substantial increase of COX-2 and IL-6 produced by the cells (Figure 6A and Figure 6B, respectively). This evidence concerns the gene IL6 and malignant colon neoplasm.